These findings are similar to model selections performed in late-onset Alzheimer’s disease, where inclusion of p-tau181, APOE status, brain imaging and cognitive testing (memory and executive) were able to predict conversion to late-onset Alzheimer’s disease in individuals with subjective cognitive impairment or mild cognitive impairment (Palmqvist et al., 2021). This evidence concerns the gene APOE and Alzheimer disease.